Baltimore, MD (ots) - -- New Tool for Detection of Minimal Residual Disease in Acute Myeloid Leukemia to Better Help in Fight Against Cancer -- Sysmex Inostics has developed a new CLIA-validated liquid biopsy test for the detection of Minimal ...To the press release of Sysmex Inostics GmbH